Karine Tawagi MD· @DrKarineTawagi · X·· 1 天前评分70
正文 · 原文
#PAPMET2 trial @maughanonc
although closed early d/t slow enrollment, still very meaningful to show more data to support IO/TKI preferred over TKI in papillary RCC
36 pts enrolled
Higher PFS & ORR with doublet
Results of STELLAR-304, SAMETA & AXIPAP are pending! #ESMO26
54 浏览 · 5 赞 · 0 转发 · 0 回复
来源：Karine Tawagi MD · x.com